Overview

Tau Imaging in Professional Fighters

Status:
Completed
Trial end date:
2017-02-03
Target enrollment:
Participant gender:
Summary
Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition.
Phase:
Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals
Collaborator:
The Cleveland Clinic